Results 101 to 110 of about 72,678 (220)

Twenty years of BRCA1 and BRCA2 molecular analysis at MMCI : current developments for the classification of variants [PDF]

open access: yes, 2019
Claes, Kathleen   +9 more
core   +2 more sources

Development of a High‐Sensitivity Electrochemical Biosensor for Domoic Acid and Its Cellular Impact on Human Stem and Neuron‐Like Cells

open access: yesFood Science &Nutrition, Volume 14, Issue 5, May 2026.
Integrated workflow of domoic acid (DA) detection in seafood using a high‐sensitivity electrochemical biosensor and subsequent evaluation of DA‐induced cellular responses. (A) DA monitoring in seafood: Marine samples (European anchovy and mussels from the Marmara and Black Sea) were collected, extracted using a 1:1 methanol/water mixture, and analyzed ...
Emilia Qomi Ekenel   +10 more
wiley   +1 more source

BRCA2 as a Low-Penetrance Cancer Gene [PDF]

open access: yesJNCI: Journal of the National Cancer Institute, 1996
openaire   +2 more sources

Breast Cancer Molecular Subtypes and Receptor‐Related Risk Factor Associations: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Breast cancer is the most common cancer among women worldwide. This study aimed to determine the frequency of breast cancer molecular subtypes and the associations of ER, PR, and HER2 status with demographic, reproductive, hormonal, and cancer stage in Qazvin, Iran (2021–2023).
Ensiyeh Bahadoran   +4 more
wiley   +1 more source

DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High‐Grade Serous Ovarian Carcinoma

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 5, May 2026.
ABSTRACT Extracellular vesicles (EVs), including exosomes, circulate in body fluids and carry pathological genomic information. High‐grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian cancer, characterized predominantly by copy number variations (CNVs).
Ryosuke Uekusa   +17 more
wiley   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld   +5 more
wiley   +1 more source

“A Much Needed Specialist Service”: Patient Perspectives on Hereditary Cancer Risk Psychology Service Delivery and Future Service Development

open access: yesPsycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Objective To evaluate a pilot specialist clinical psychology service for patients who have hereditary risk of breast and ovarian cancer (HBOC). Methods Multi‐method study reviewing 51 patients' demographic data, their engagement with the service and psychological assessment data (PHQ‐9 and GAD‐7).
Sara Scardini   +4 more
wiley   +1 more source

MAVISp: A modular structure‐based framework for protein variant effects

open access: yesProtein Science, Volume 35, Issue 5, May 2026.
Abstract The role of genomic variants in disease has expanded significantly with the advent of advanced sequencing techniques. The rapid increase in identified genomic variants has led to many variants being classified as Variants of Uncertain Significance or as having conflicting evidence, posing challenges for their interpretation and ...
Matteo Arnaudi   +32 more
wiley   +1 more source

Home - About - Disclaimer - Privacy